MicuRx Pharmaceuticals is Drug Discovery in China that focus on biopharmaceutical platform business. Founded in 2007. They cover business area such as developer, antibiotic, improved safety profile, resistant bacterial infection, compound, contezolid acefosamil, next-generation oxazolidinone, methicillin resistant S. aureus, MRSA, hematological adverse event, patient, healthcare institution.
2007
( 17 years old in 2024 )
Biopharmaceutical Platform
-
720 Cailun Road, Building 2, Suite 401
Zhanjiang Hi-Tech Park
Shanghai, Pudong District
China
Private
developerantibioticimproved safety profileresistant bacterial infectioncompoundcontezolid acefosamilnext-generation oxazolidinonemethicillin resistant S. aureusMRSAhematological adverse eventpatienthealthcare institution
* We use standard office opening hours in near MicuRx Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MicuRx Pharmaceuticals is Drug Discovery business from China that founded in 2007 (17 years old in 2024), MicuRx Pharmaceuticals business is focusing on Biopharmaceutical Platform.
MicuRx Pharmaceuticals headquarter office and corporate office address is located in 720 Cailun Road, Building 2, Suite 401 Zhanjiang Hi-Tech Park Shanghai, Pudong District China.
MicuRx Pharmaceuticals was founded in China.
In 2024, MicuRx Pharmaceuticals is currently focus on biopharmaceutical platform sector.
Above is snippet of Google Trends for "biopharmaceutical platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MicuRx Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
